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Abstract
Tumors of the gastroesophageal junction are among the most frequent cancers in the upper gastrointestinal tract. Here the
authors demonstrate morphologic ﬁndings, classiﬁcation according to the Siewert classiﬁcation, and endosonographic
staging. This article is part of an expert video encyclopedia.
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Materials
• Endoscope: GIF-H180; Olympus, Japan.
• Endoscopic ultrasound (EUS) system: EUB-8500, EG-
3630UR; Hitachi, Japan.
Background and Endoscopic Procedures
Tumors of the gastroesophageal junction (GEJ) are among the
most frequent cancers in the upper gastrointestinal tract.
Endoscopically, the GEJ corresponds to the most proximal
extent of the longitudinal gastric folds.1 For staging of
esophageal and gastric neoplasias, the tumor – lymph node –
metastasis (TNM) staging system of the American Joint
Committee on Cancer/International Union Against Cancer is
used universally. In the latest (7th) edition of the TNM Staging
Manual, GEJ tumors are deﬁned as those arising at the GEJ or
in the cardia of the stomach within 5 cm of the GEJ and that
extend into the GEJ or the esophagus.1 These tumors are
staged as esophageal rather than gastric cancers.
First, upper endoscopy is needed to establish tumor diag-
nosis by multiple biopsies and classiﬁcation of the tumor type
(according to the classiﬁcation by Siewert I–III),2 which is
based on the localization of the neoplasia in relation to cardia.
• Type I: Adenocarcinoma of the distal esophagus, with or
without inﬁltration of the GEJ.
• Type II: True carcinoma of the gastric cardia, arising from
the cardiac epithelium or short segments with intestinal
metaplasia at the GEJ. Type II tumors are located between
1 cm proximal and 2 cm distal to the anatomical cardia.
• Type III: Subcardial gastric carcinoma, which inﬁltrates the
GEJ and distal esophagus from below.
All other tumors with a center in the stomach45 cm from
the GEJ, or those tumors within 5 cm of the GEJ without ex-
tension into the esophagus, are staged as gastric cancers.
Preoperative TNM staging is essential for therapeutic de-
cision making. EUS is useful to determine the tumor category
and to assess the presence of lymph node metastases.
Endoscopic visualization needs to be performed in retro-
ﬂexion to clearly describe the tumor extension below the cardia.
Multiple biopsies (up to seven) should be taken to increase
diagnostic accuracy up to 98%.3 Patients without evidence of
an underlying metastatic disease should undergo EUS, the most
accurate technique for locoregional staging for esophageal and
especially tumors at the GEJ,4 providing detailed images of
esophageal masses according to the ﬁve-layered structure of the
esophageal wall, with an overall accuracy for the tumor and the
lymph node staging of 80–90%. However, in T2 tumors, sen-
sitivity of EUS is very low (43%), with a frequently described
risk of overstaging.5
Key Learning Points/Tips and Tricks
• Proper endoscopic evaluation of the subcardial region
using inversion is mandatory.
• For description of the localization of neoplasias at the GEJ,
Siewert classiﬁcation type I–III should be used with
consequent different surgical approaches.
• EUS is the most sensitive tool for N staging and has a high
sensitivity for T3 cancers, but not for T2 neoplasias.
Therefore, be aware of the high risk of overstaging T2
tumors with EUS.
This article is part of an expert video encyclopedia. Click here for the full
Table of Contents.
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Scripted Voiceover
Time
(min:sec)
Voiceover text
00:00 This is a 79-year-old patient referred for endoscopic
staging of an adenocarcinoma at the gastroesophageal
junction. This patient has a small hiatus hernia. The
tumor measures 20 mm in the maximal diameter and is
located 1 cm proximal of the cardia. In patients with
small hernias complete visualization and evaluation of
this location is often difﬁcult in the prograde position of
the endoscope.
00:33:16 After inversion of the endoscope we can clearly see the
neoplastic nodule in the direct neighborhood of the
cardia. Tumors like this, which have centers within 5 cm
of, and extend to the gastroesophageal junction, are
classiﬁed as esophageal carcinoma, while other tumors
that have their centers more than 5 cm distal of the
gastroesophageal junction are classiﬁed as gastric
carcinoma. According to the Siewert classiﬁcation this is
a Type II tumor, classiﬁed as true carcinoma of the
gastric cardia, arising from the cardiac epithelium or
short segments with intestinal metaplasia at the
gastroesophageal junction.
01:25:18 Endoscopic ultrasound using electronic radial endoscopic
ultrasonography reveals an irregular hypoechoic mass
that inﬁltrates the muscularis propria but does not
penetrate it. This invasion depth is classiﬁed as a T2
tumor.
01:46:18 However, the arrow points to a small area that is
suspicious for a transmural invasion through the
esophageal wall. Enlarged local lymph nodes are not
detected. The ﬁnal endosonographic diagnosis in this
patient is T2 or T3 tumor without lymph node invasion.
The patient refused combined modality therapy and
underwent surgery alone with the ﬁnal diagnosis of an
adenocarcinoma of the gastroesophageal junction pT2,
pN0 (0/24), M0, International Union Against Cancer
classiﬁcation type IB with no indication for an adjuvant
treatment.
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